Weekly Policy Update: Biden’s Spending Proposal Signals Key Healthcare Priorities
By: Colorado BioScience Association Date: 04/16/2021
Last week the White House unveiled a $1.5 trillion discretionary spending request for the coming fiscal year. The request, which is only part of the President’s full budget proposal, is a sharp depart...
Learn MoreYour Help Needed Now: Tell Colorado Legislators to Protect Life Sciences Innovation
By: Colorado BioScience Association Date: 04/09/2021
The Colorado state legislature is considering a bill that creates a state drug review board with the power to set payment rates for medicines in Colorado. The unelected board could set price limits wi...
Learn MoreWeekly Policy Update: CBSA Convenes Roundtable Discussion with Congressman Joe Neguse
By: Colorado BioScience Association Date: 04/09/2021
CBSA convened a virtual roundtable this week with Congressman Joe Neguse, who represents Colorado’s second Congressional district. It was a great opportunity for leaders in our ecosystem to highlight...
Learn MoreWeekly Policy Update: New Study Examines Impact of Federal Drug Pricing Proposal
By: Colorado BioScience Association Date: 04/02/2021
Last week, the Council of State Bioscience Associations released a new study that shows the impact of foreign reference pricing on patient access to lifesaving medicines and investment in new treatmen...
Learn MoreWeekly Policy Update: State Leaders Solicit Input on Colorado’s Stimulus Funding
By: Colorado BioScience Association Date: 03/26/2021
Colorado and local governments are expected to receive billions of dollars from the 2021 American Rescue Plan. In an effort to better understand the needs and current economic challenges facing the st...
Learn MoreWeekly Policy Update: CBSA Testifies on Local Impact of Drug Pricing Bill
By: Colorado BioScience Association Date: 03/19/2021
This week CBSA testified in opposition to Senate Bill 175 in the Senate Health & Human Services Committee. The bill would create a prescription drug review board in Colorado that’s charged with re...
Learn MoreWeekly Policy Update: CBSA Engages on Key Legislation
By: Colorado BioScience Association Date: 03/12/2021
CBSA took new positions on several bills in the 2021 legislative session. Here is a recap of what happened this week. New Funding for Advanced Industries Grant Program: On Tuesday, the legislature pas...
Learn MorePolicy + Advocacy: Legislature Passes New Funding for Advanced Industries Accelerator Grant Program
By: Colorado BioScience Association Date: 03/09/2021
On Tuesday, the Colorado General Assembly passed Senate Bill 42, which includes a one-time, $10 million infusion for the Advanced Industries Accelerator Grant Program. Governor Polis is expected to si...
Learn MoreWeekly Policy Update: CBSA Shares Survey Insights
By: Colorado BioScience Association Date: 03/05/2021
The CBSA Policy + Advocacy team works to engage state and federal policymakers on issues that are critical to our members and Colorado’s life sciences ecosystem. Last month, CBSA conducted a survey to...
Learn MoreWeekly Policy Update: CBSA Takes Positions on New State Legislation
By: Colorado BioScience Association Date: 02/26/2021
The Colorado state legislature returned on February 16th to continue the 2021 session, and there have already been almost 300 bills introduced so far. CBSA’s Policy + Advocacy team has been hard at wo...
Learn More